advantagetherapeutics.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: Sitemap: | ||
Meta Tags
| Title | Advantage Therapeutics - A new Vantage on Alzheimer’s |
| Description | Mission: We are developing a novel immunotherapy for early |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 188.114.96.3 |
| Location | Spain |
Related Websites
| Site | Rank |
More to Explore
advantagetherapeutics.com Valuation
|
US$764
Last updated: 2023-05-20 00:05:32
advantagetherapeutics.com has Semrush global rank of 0. advantagetherapeutics.com has an estimated worth of US$ 764, based on its estimated Ads revenue. advantagetherapeutics.com receives approximately 88 unique visitors each day. Its web server is located in Spain, with IP address 188.114.96.3. According to SiteAdvisor, advantagetherapeutics.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$764 |
| Daily Ads Revenue | US$0 |
| Monthly Ads Revenue | US$21 |
| Yearly Ads Revenue | US$254 |
| Daily Unique Visitors | 5 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| advantagetherapeutics.com. 299 | A | advantagetherapeutics.com. 299 | IP: 188.114.96.3 |
| advantagetherapeutics.com. 299 | A | advantagetherapeutics.com. 299 | IP: 188.114.97.3 |
| advantagetherapeutics.com. 299 | AAAA | advantagetherapeutics.com. 299 | IPV6: 2a06:98c1:3121::3 |
| advantagetherapeutics.com. 299 | AAAA | advantagetherapeutics.com. 299 | IPV6: 2a06:98c1:3120::3 |
| advantagetherapeutics.com. 86400 IN | NS | NS Record: dave.ns.cloudflare.com. | |
| advantagetherapeutics.com. 86400 IN | NS | NS Record: may.ns.cloudflare.com. | |
| advantagetherapeutics.com. 300 | MX | advantagetherapeutics.com. 300 | MX Record: 10 advantagetherapeutics-com.mail.protection.outlook.com. |
| advantagetherapeutics.com. 300 | TXT | advantagetherapeutics.com. 300 | TXT Record: MS=ms19697183 |
| advantagetherapeutics.com. 300 | TXT | advantagetherapeutics.com. 300 | TXT Record: google-site-verification=K93cKJ2lsuk26ufDaI1kQFMkKwa2VBNsElb7Utf0h7g |
| advantagetherapeutics.com. 300 | TXT | advantagetherapeutics.com. 300 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-20 00:05:32
| About Us Our Science Pipeline Our Team News A NEW VANTAGE ON ALZHEIMER’S DISEASE We are developing a novel immunotherapy for early AD. Our Mission Mission: Produce safety and efficacy data for our lead therapeutic that warrants approval. ADvantage Therapeutics is developing therapies to treat neurodegenerative conditions with a major focus on Alzheimer’s Disease (AD). We are currently preparing for clinical trials in Europe and in the US. Furthermore, ADvantage is developing potentially paradigm-changing therapies to treat AD in its labs at the Vienna BioCenter. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video MORE ABOUT US Our Breakthrough The most fruitful basis of the discovery of a new drug is to start with an old drug. ~ Sir James W. Black, 1988 Nobel Prize in Medicine We will sustain a knowledge-building culture, rooted in win-win relationships, that combines leading-edge scientific skill, unencumbered by conventional |
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Tue, 13 Dec 2022 09:02:25 GMT
Connection: keep-alive
Cache-Control: max-age=3600
Expires: Tue, 13 Dec 2022 10:02:25 GMT
Location: https://advantagetherapeutics.com/
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=hUfpvZ5VLE9MRQmOJ%2BNQJdLQIR0pgTu5QOweGUmJ02yDMqzkLlX%2BG0u4XvVWuaZvX1li1j5EizfZmcmdYprbCklcrM3GYdA0S4poq4Ti7fo13ToGFE0pq5r6TmY2mkheUNuQ%2BtQ403gTW%2BTbltfix4kCvFYVeTCJ"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 778d854f59da68fe-FRA
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
HTTP/2 200
date: Tue, 13 Dec 2022 09:02:26 GMT
content-type: text/html; charset=UTF-8
cf-edge-cache: cache,platform=wordpress
link:
|
advantagetherapeutics.com Whois Information
Domain Name: ADVANTAGETHERAPEUTICS.COM Registry Domain ID: 2032196953_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.psi-usa.info Registrar URL: http://www.psi-usa.info Updated Date: 2022-05-30T07:31:37Z Creation Date: 2016-05-29T19:29:50Z Registry Expiry Date: 2023-05-29T19:29:50Z Registrar: PSI-USA, Inc. dba Domain Robot Registrar IANA ID: 151 Registrar Abuse Contact Email: domain-abuse@psi-usa.info Registrar Abuse Contact Phone: +49.94159559482 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DAVE.NS.CLOUDFLARE.COM Name Server: MAY.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2022-12-13T08:45:34Z <<< |